Pretreatment hemoglobin, myeloma subtype, and induction regimens as independent prognostic factors for survival after autologous stem cell transplantation in multiple myeloma: a retrospective cohort study
Pretreatment hemoglobin, IgG subtype, and bortezomib-based induction are independent predictors of survival after auto-HSCT. Hb, a simple and widely available marker, adds prognostic value beyond ISS and cytogenetics. Integrating these factors into prognostic models can help tailor therapy and improve patient management.
Authors
- Lu Wen (ORCID: https://orcid.org/0000-0002-1773-1876)
- Yongqing Zhang (ORCID: https://orcid.org/0000-0003-0581-4882)
- Wenming Chen (ORCID: https://orcid.org/0000-0001-6298-8489)
- Yang Guang-zhong
Institutions
- Capital University (US)
- Capital Medical University (CN)
- Beijing Chao-Yang Hospital, Capital Medical University (CN)
- Aviation General Hospital (CN)
Publication Details
- Journal
- Hematology
- Published
- 2025-10-14
- DOI
- https://doi.org/10.1080/16078454.2025.2566570
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00